Catalyst Pharms Company Profile

✉ Email this page to a colleague

CATALYST PHARMS has four approved drugs.

There are fourteen US patents protecting CATALYST PHARMS drugs.

There are one hundred and thirty-three patent family members on CATALYST PHARMS drugs in thirty-four countries and nineteen supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Catalyst Pharms	AGAMREE	vamorolone	SUSPENSION;ORAL	215239-001	Oct 26, 2023		RX	Yes	Yes	10,857,161	⤷ Try a Trial	Y			⤷ Try a Trial
Catalyst Pharms	AGAMREE	vamorolone	SUSPENSION;ORAL	215239-001	Oct 26, 2023		RX	Yes	Yes	11,833,159	⤷ Try a Trial	Y			⤷ Try a Trial
Catalyst Pharms	FIRDAPSE	amifampridine phosphate	TABLET;ORAL	208078-001	Nov 28, 2018		RX	Yes	Yes	11,274,332	⤷ Try a Trial				⤷ Try a Trial
Catalyst Pharms	FYCOMPA	perampanel	TABLET;ORAL	202834-002	Oct 22, 2012		RX	Yes	No	6,949,571	⤷ Try a Trial	Y	Y		⤷ Try a Trial
Catalyst Pharms	FIRDAPSE	amifampridine phosphate	TABLET;ORAL	208078-001	Nov 28, 2018		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Catalyst Pharms	FYCOMPA	perampanel	TABLET;ORAL	202834-004	Oct 22, 2012		RX	Yes	No	8,772,497	⤷ Try a Trial		Y		⤷ Try a Trial
Catalyst Pharms	AGAMREE	vamorolone	SUSPENSION;ORAL	215239-001	Oct 26, 2023		RX	Yes	Yes	11,471,471	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg	➤ Subscribe	2016-10-24

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2013003708	⤷ Try a Trial
New Zealand	589444	⤷ Try a Trial
South Africa	200609274	⤷ Try a Trial
Denmark	1764361	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2006004100	⤷ Try a Trial
Poland	1772450	⤷ Try a Trial
Norway	339101	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1300396	CA 2012 00052	Denmark	⤷ Try a Trial
1300396	2012/049	Ireland	⤷ Try a Trial	PRODUCT NAME: PERAMPANEL, OPTIONALLY A SALT OR HYDRATE THEREOF.; REGISTRATION NO/DATE: EU/1/12/776/001-EU/1/12/776/016 20120723
1300396	300565	Netherlands	⤷ Try a Trial	PRODUCT NAME: PERAMPANEL, EEN ZOUT OF EEN HYDRAAT ERVAN; REGISTRATION NO/DATE: EU/1/12/776/001 .....016 20120723
1300396	C300566	Netherlands	⤷ Try a Trial	PRODUCT NAME: PERAMPANEL, EEN ZOUT OF EEN HYDRAAT DAARVAN; REGISTRATION NO/DATE: EU/1/12/776/001 .... 016 20120723
1300396	SPC/GB12/057	United Kingdom	⤷ Try a Trial	PRODUCT NAME: PERAMPANEL, OPTIONALLY IN THE FORM OF A SALT OR HYDRATE; REGISTERED: UK EU/1/12/776/001- 016 20120723
1300396	420	Finland	⤷ Try a Trial
1300396	C01300396/01	Switzerland	⤷ Try a Trial	PRODUCT NAME: PERAMPANEL; REGISTRATION NO/DATE: SWISSMEDIC 62440 14.12.2012
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.